Giulia Ribelli
Impact in
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
- Oncology top 10%
- Bone health and treatments
- Cancer Cells and Metastasis
- Cancer Diagnosis and Treatment
Papers in
- Oncology 13
- Bone health and treatments 10
- Cancer Cells and Metastasis 3
-
- Prostate Cancer Treatment and Research 4
- Sarcoma Diagnosis and Treatment 3
- Co-authors
- Francesco Pantano (19 shared papers)Michele Iuliani (19 shared papers)Daniele Santini (19 shared papers)Giuseppe Tonini (19 shared papers)Bruno Vincenzi (17 shared papers)Marco Fioramonti (10 shared papers)Sonia Simonetti (8 shared papers)Francesca Romana Bertani (1 shared paper)
- Journals
- Scientific Reports (3 papers)Frontiers in Oncology (2 papers)Journal of Clinical Oncology (2 papers)Oncotarget (2 papers)Oncogene (1 paper)
- Partner nations
- ItalyUnited KingdomGermany
In The Last Decade
Giulia Ribelli
18 papers receiving 669 citations
Peers
Comparison fields: 5 of 90
- Cancer Research 157
- Oncology 262
- Immunology 114
- Pulmonary and Respiratory Medicine 164
- Immunology and Allergy 21
Countries citing papers authored by Giulia Ribelli
This map shows the geographic impact of Giulia Ribelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giulia Ribelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giulia Ribelli more than expected).
Fields of papers citing papers by Giulia Ribelli
This network shows the impact of papers produced by Giulia Ribelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giulia Ribelli. The network helps show where Giulia Ribelli may publish in the future.
Co-authors
The 25 scholars most cited alongside Giulia Ribelli, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 182 | |
| 2 | 2020 | 180 | |
| 3 | 2021 | 73 | |
| 4 | 2018 | 39 | |
| 5 | 2015 | 36 | |
| 6 | 2017 | 31 | |
| 7 | 2015 | 28 | |
| 8 | 2020 | 26 | |
| 9 | 2020 | 17 | |
| 10 | 2017 | 16 | |
| 11 | 2020 | 14 | |
| 12 | 2022 | 12 | |
| 13 | 2021 | 6 | |
| 14 | 2021 | 4 | |
| 15 | 2015 | 3 | |
| 16 | 2016 | 3 | |
| 17 | 2016 | 1 | |
| 18 | 2016 | 1 | |
| 19 | 2015 | 0 |
About Giulia Ribelli
Giulia Ribelli is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Cancer Research, having authored 19 papers that have together received 672 indexed citations. Recurring topics across this work include Bone health and treatments (10 papers), Radiopharmaceutical Chemistry and Applications (5 papers), Prostate Cancer Treatment and Research (4 papers), Sarcoma Diagnosis and Treatment (3 papers), Cancer Cells and Metastasis (3 papers), Chronic Myeloid Leukemia Treatments (2 papers), Histone Deacetylase Inhibitors Research (2 papers) and Bone Metabolism and Diseases (2 papers). The work is most often cited by research in Cancer Research (157 citations), Oncology (262 citations), Immunology (114 citations), Pulmonary and Respiratory Medicine (164 citations) and Immunology and Allergy (21 citations). Giulia Ribelli has collaborated with scholars based in Italy, United Kingdom and Germany. Frequent co-authors include Francesco Pantano, Michele Iuliani, Daniele Santini, Giuseppe Tonini, Bruno Vincenzi, Marco Fioramonti, Sonia Simonetti, Francesca Romana Bertani, Pamela Mozetic and S. Selci. Their work appears in journals such as Scientific Reports, Frontiers in Oncology, Journal of Clinical Oncology, Oncotarget and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.